POTENTIAL SIDE EFFECT OF INADVERTENT INTRAVASCULAR ADMINISTRATION OF LIPOSOMAL BUPIVACAINE. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE A 12-MONTH EXTENSION TO CLIN 0001 (THROUGH 31 MAY 2019) AT NO ADDITIONAL COST TO THE GOVERNMENT.
$-5,732FY2018Department of the ArmyDOD
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc.